A nanoparticle-based “prime and pull” vaccine strategy resulted in strong immune responses in vaginal tissue. In preclinical ...

Genital herpes is a lifelong infection. While available treatments can manage symptoms, they cannot cure the infection or prevent transmission.

A landmark study due to start in the coming months aims to test a method for rejuvenating our immune system in older age. The ...

Scientists at The Wistar Institute have shown that a single injection of a small, circular piece of genetic instructions can ...

Genital herpes is a lifelong infection. While available treatments can manage symptoms, they cannot cure the infection or prevent transmission. Now, Yale School of Medicine researchers have taken a ...

Scientists at The Wistar Institute have shown that a single injection of a small, circular piece of genetic instructions can ...

Data from LIBERTY can provide important insight into the VYD2311 clinical profile by direct comparison between COVID antibody prophylaxis and COVID vaccine LIBERTY is part of Invivyd’s broader ...

LIBERTY clinical trial will evaluate the comparative safety and tolerability of VYD2311 versus mRNA COVID-19 vaccine, as well as explore the safety and immunology of co-administer ...

DECLARATION is a Phase 3, randomized, placebo-controlled clinical trial to evaluate the safety and efficacy of VYD2311 in the prevention of symptomatic COVID-19 versus placebo, at three months, from a ...

Preliminary H1 2026 revenue of approximately $11 million, increased 120% vs. H1 2025, underscoring strong operating momentum. Supported by approximately ...

The global long-acting drugs market is growing steadily, expected to be valued at around US$ 7.2 billion in 2026 and projected to reach US$ 13.3 billion by 2033, with a CAGR of 8.9% in the coming ...